Form 13-F position report

UNITY BIOTECHNOLOGY INC

Reported by Virtus ETF Advisers LLC

UBX CUSIP 91381U101 Manager CIK 0001587281

Reported 0 shares, down 43,010 (100.0%) from the prior quarter.

Reported value -100.0%; share count -100.0% vs. the prior quarter.

Reduced
% of reported 13F value 0 This manager · Q2 2020
Shares 0 Quarter-end amount reported
Reported value $0 Fair value at quarter end
Consecutive quarters held 7 Through Q2 2020

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value

Quarterly position history

How this manager's reported quarter-end position changed over time.

0 quarters
Quarterly reported position history for UNITY BIOTECHNOLOGY INC held by Virtus ETF Advisers LLC.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
This position's reported history falls outside the five-year preview window. A free account unlocks it. Unlock full history

Who else reported the position

88 managers reported UNITY BIOTECHNOLOGY INC for Q2 2020.

Managers reporting UNITY BIOTECHNOLOGY INC in Q2 2020.
Manager Activity Shares Change % of reported 13F Reported value Tenure
FMR LLC Added 6,098,817 +348,328 < 0.01% $52,938,000 9 qtrs
BAILLIE GIFFORD & CO Unchanged 3,803,014 0 0.03% $33,011,000 9 qtrs
BlackRock Inc Added 2,892,352 +684,343 < 0.01% $25,105,000 9 qtrs
Invus Financial Advisors LLC Unchanged 2,189,998 0 6.87% $19,009,000 3 qtrs
Capital World Investors Unchanged 1,835,000 0 < 0.01% $15,928,000 9 qtrs
Mayo Clinic Unchanged 1,571,981 0 13.06% $13,645,000 3 qtrs
VANGUARD GROUP INC Added 1,443,995 +314,394 < 0.01% $12,534,000 9 qtrs
STATE STREET CORPORATION Added 576,128 +111,587 < 0.01% $5,001,000 9 qtrs
MILLENNIUM MANAGEMENT LLC Added 532,047 +501,282 < 0.01% $4,618,000 8 qtrs
GEODE CAPITAL MANAGEMENT LLC Added 465,555 +63,883 < 0.01% $4,041,000 9 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
June 30, 2020
Filed
August 05, 2020
Filing type
13F-HR
Position type
COM

Voting authority reported

No voting-authority amounts were reported for this position. Voting authority is not required for reported call options.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.